Latest Insider Transactions at Edwards Lifesciences Corp (EW)
This section provides a real-time view of insider transactions for Edwards Lifesciences Corp (EW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Edwards Lifesciences Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Edwards Lifesciences Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,250
-27.02%
|
$787,500
$70.87 P/Share
|
|
Mar 26
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+21.27%
|
$506,250
$45.28 P/Share
|
|
Mar 13
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
9,500
-16.83%
|
$636,500
$67.96 P/Share
|
|
Mar 13
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
9,500
+14.41%
|
$427,500
$45.28 P/Share
|
|
Mar 10
2025
|
Bernard J Zovighian CEO |
BUY
Bona fide gift
|
Indirect |
1,299
+11.07%
|
-
|
|
Mar 10
2025
|
Bernard J Zovighian CEO |
SELL
Open market or private sale
|
Direct |
6,164
-9.45%
|
$425,316
$69.51 P/Share
|
|
Mar 10
2025
|
Bernard J Zovighian CEO |
SELL
Bona fide gift
|
Direct |
1,299
-1.95%
|
-
|
|
Mar 10
2025
|
Bernard J Zovighian CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,463
+10.08%
|
$335,835
$45.28 P/Share
|
|
Mar 10
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
400
-1.74%
|
$27,600
$69.48 P/Share
|
|
Mar 10
2025
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.71%
|
$18,000
$45.28 P/Share
|
|
Feb 28
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,250
-14.36%
|
$787,500
$70.95 P/Share
|
|
Feb 28
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+21.27%
|
$506,250
$45.28 P/Share
|
|
Feb 22
2025
|
Andrew M. Dahl SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
176
-3.62%
|
$12,848
$73.3 P/Share
|
|
Feb 18
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
222
-0.97%
|
$16,872
$76.19 P/Share
|
|
Feb 17
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-0.72%
|
$12,540
$76.19 P/Share
|
|
Feb 16
2025
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
333
-0.17%
|
$25,308
$76.19 P/Share
|
|
Feb 16
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
174
-0.57%
|
$13,224
$76.19 P/Share
|
|
Feb 16
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
214
-0.92%
|
$16,264
$76.19 P/Share
|
|
Feb 14
2025
|
Steven R Loranger Director |
SELL
Open market or private sale
|
Direct |
5,739
-8.68%
|
$436,164
$76.42 P/Share
|
|
Feb 14
2025
|
Steven R Loranger Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,739
+7.99%
|
$258,255
$45.32 P/Share
|
|
Feb 13
2025
|
Heisz Leslie Stone Director |
SELL
Open market or private sale
|
Direct |
5,739
-16.04%
|
$430,425
$75.86 P/Share
|
|
Feb 13
2025
|
Heisz Leslie Stone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,739
+13.82%
|
$258,255
$45.32 P/Share
|
|
Feb 13
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
500
-2.11%
|
$38,000
$76.34 P/Share
|
|
Feb 13
2025
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.07%
|
$22,500
$45.28 P/Share
|
|
Feb 13
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
6,500
-6.09%
|
$494,000
$76.0 P/Share
|
|
Feb 13
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+10.85%
|
$292,500
$45.28 P/Share
|
|
Feb 13
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,250
-26.91%
|
$843,750
$75.76 P/Share
|
|
Feb 13
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+21.2%
|
$506,250
$45.28 P/Share
|
|
Jan 16
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,000
-9.63%
|
$340,000
$68.75 P/Share
|
|
Jan 16
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.78%
|
$225,000
$45.28 P/Share
|
|
Jan 16
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
500
-2.11%
|
$34,000
$68.76 P/Share
|
|
Jan 16
2025
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.07%
|
$22,500
$45.28 P/Share
|
|
Dec 16
2024
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
2,500
-9.73%
|
$185,000
$74.08 P/Share
|
|
Dec 16
2024
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+8.87%
|
$112,500
$45.28 P/Share
|
|
Dec 09
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,000
-9.63%
|
$355,000
$71.75 P/Share
|
|
Dec 09
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.78%
|
$225,000
$45.28 P/Share
|
|
Dec 09
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,250
-26.91%
|
$798,750
$71.68 P/Share
|
|
Dec 09
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+21.2%
|
$506,250
$45.28 P/Share
|
|
Dec 06
2024
|
Wayne Markowitz GM & SVP, Surgical |
SELL
Open market or private sale
|
Direct |
583
-5.79%
|
$42,559
$73.27 P/Share
|
|
Dec 06
2024
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
1,750
-5.97%
|
$127,750
$73.27 P/Share
|
|
Nov 13
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,000
-9.63%
|
$325,000
$65.57 P/Share
|
|
Nov 13
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.78%
|
$225,000
$45.28 P/Share
|
|
Nov 05
2024
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
25,000
-11.18%
|
$1,625,000
$65.91 P/Share
|
|
Oct 15
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,000
-9.63%
|
$345,000
$69.51 P/Share
|
|
Oct 15
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.78%
|
$225,000
$45.28 P/Share
|
|
Sep 14
2024
|
Wayne Markowitz GM & SVP, Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
648
-6.07%
|
$44,064
$68.52 P/Share
|
|
Sep 13
2024
|
Andrew M. Dahl SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,920
+38.37%
|
-
|
|
Sep 11
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,000
-9.63%
|
$330,000
$66.77 P/Share
|
|
Sep 11
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.78%
|
$225,000
$45.28 P/Share
|
|
Sep 03
2024
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
5,530
-6.37%
|
$381,570
$69.96 P/Share
|